title: [Use of anxiolytics and antidepressants before and after treatment with interferon-alpha and ribavirin in patients with hepatitis C].
authors.forename: Mauro
authors.initials: M
authors.lastname: García-Toro
authors.forename: Angels
authors.initials: A
authors.lastname: Vilella Martorell
authors.forename: María
authors.initials: M
authors.lastname: Carral Martínez
authors.forename: Teresa
authors.initials: T
authors.lastname: Jimeno Beltrán
authors.forename: Yolanda
authors.initials: Y
authors.lastname: Román Ruiz del Moral
authors.forename: Carmen
authors.initials: C
authors.lastname: Pradas Guerrero
authors.forename: Margalida
authors.initials: M
authors.lastname: Gili Planas
authors.forename: Miguel
authors.initials: M
authors.lastname: Roca Bennasar
mesh_terms: D014151:Anti-Anxiety Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000928:Antidepressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D001007:Anxiety / Q000139:chemically induced* / Q000188:drug therapy / Q000453:epidemiology; D003863:Depression / Q000139:chemically induced* / Q000188:drug therapy / Q000453:epidemiology; D004359:Drug Therapy, Combination; D006526:Hepatitis C / Q000188:drug therapy* / Q000523:psychology; D006801:Humans; D015994:Incidence; D016898:Interferon-alpha / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D012189:Retrospective Studies; D012254:Ribavirin / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D014151:Anti-Anxiety Agents; D000928:Antidepressive Agents; D000998:Antiviral Agents; D016898:Interferon-alpha; D012254:Ribavirin